BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 30692286)

  • 1. [A Case of Advanced Gastric Cancer with Peritoneal Dissemination after Gastrectomy Effectively Treated with Combination Chemotherapy of Ramucirumab and Paclitaxel].
    Muroya T; Wajima N; Kubo N; Yoshida E; Akaishi T; Umetsu S; Yoshida T; Wakasa Y; Sato K; Mitsuhashi Y; Umemura K; Ogasawara H; Hara Y; Hakamada K
    Gan To Kagaku Ryoho; 2018 Dec; 45(13):2066-2068. PubMed ID: 30692286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A Case of Advanced Gastric Cancer with Peritoneal Dissemination after Gastrectomy Successfully Treated with Paclitaxel plus Ramucirumab].
    Miyamoto K; Tadano Y; Itoh R
    Gan To Kagaku Ryoho; 2021 Jan; 48(1):113-114. PubMed ID: 33468738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Preoperative combination chemotherapy with TS-1 is effective in a case gastric cancer with peritoneal dissemination].
    Nakamura R; Saikawa Y; Kubota T; Nakamura T; Akatsu Y; Takahashi T; Yoshida M; Otani Y; Kumai K; Kitajima M
    Gan To Kagaku Ryoho; 2005 Sep; 32(9):1323-6. PubMed ID: 16184933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of advanced gastric cancer with peritoneal dissemination recurrence after gastrectomy effectively treated with combination chemotherapy of S-1 and docetaxel].
    Wada Y; Okada K; Ebisui C; Kato R; Makino S; Takeoka T; Yanagisawa T; Okamura S; Fukuchi N; Murata K; Yokouchi H; Kinuta M
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):2244-6. PubMed ID: 24394073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of gastric cancer with peritoneal dissemination which has been alive more than three years responding to intraperitoneal chemotherapy].
    Asami S; Idani H; Kubo S; Sasaki H; Kurose Y; Nojima H; Yoshioka T; Muro M; Kumano K; Hirata M; Yamashita T; Kin H; Takakura N
    Gan To Kagaku Ryoho; 2009 Nov; 36(12):2287-9. PubMed ID: 20037398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A recurrent gastric cancer with peritoneal metastasis 15 years after distal gastrectomy successfully treated with S-1 and weekly intravenous and intraperitoneal injections of Paclitaxel].
    Iwai N; Wakabayashi N; Matsumoto N; Morita Y; Tanaka N; Yoriki H; Fujii K; Takada R; Takaya H; Masuzawa A; Takami S; Kataoka K
    Gan To Kagaku Ryoho; 2015 Mar; 42(3):351-4. PubMed ID: 25812506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of advanced type 4 gastric cancer with peritonitis dissemination, navel metastasis effectively treated with combined chemotherapy of biweekly paclitaxel (TXL) and TS-1].
    Hokita S; Takatori H; Ishigami S; Miyazono F; Maeda S; Arima H; Natsugoe S; Takao S; Aikou T; Hamada N
    Gan To Kagaku Ryoho; 2003 Sep; 30(9):1343-6. PubMed ID: 14518418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites.
    Kitayama J; Ishigami H; Yamaguchi H; Yamashita H; Emoto S; Kaisaki S; Watanabe T
    Ann Surg Oncol; 2014 Feb; 21(2):539-46. PubMed ID: 23975319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings.
    Ishigami H; Yamaguchi H; Yamashita H; Asakage M; Kitayama J
    Gastric Cancer; 2017 Mar; 20(Suppl 1):128-134. PubMed ID: 28028665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of advanced gastric cancer with peritoneal dissemination responding to S-1/CDDP neoadjuvant chemotherapy].
    Mizutani S; Oyama T; Uchikoshi F; Yoshidome K; Tori M; Ueshima S; Hiraoka K; Yamagami Y; Takahashi H; Nakahara M
    Gan To Kagaku Ryoho; 2007 Nov; 34(11):1853-6. PubMed ID: 18030023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weekly paclitaxel plus ramucirumab versus weekly nab-paclitaxel plus ramucirumab for unresectable advanced or recurrent gastric cancer with peritoneal dissemination refractory to first-line therapy-the P-SELECT trial (WJOG10617G)-a randomised phase II trial by the West Japan Oncology Group.
    Hirata K; Hamamoto Y; Ando M; Imamura CK; Yoshimura K; Yamazaki K; Hironaka S; Muro K
    BMC Cancer; 2020 Jun; 20(1):548. PubMed ID: 32532230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case report of curative resection for gastric cancer with peritoneal dissemination successfully treated by combined chemotherapy of S-1 and paclitaxel].
    Yamaki S; Iwata S; Ohtsuka K; Kitaoka A; Masumoto H; Katoh H
    Gan To Kagaku Ryoho; 2008 May; 35(5):821-3. PubMed ID: 18487921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of gastric cancer with peritoneal dissemination responding to combination chemotherapy with oral fluoropyrimidine and weekly paclitaxel].
    Tokunaga Y; Sasaki H; Saitou T
    Gan To Kagaku Ryoho; 2008 Jun; 35(6):999-1001. PubMed ID: 18633233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A Case of Gastric Cancer with Peritoneal Dissemination Effectively Treated with Ramucirumab and Paclitaxel].
    Seo S; Suzuki T; Misumi T; Tashiro H
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1305-1307. PubMed ID: 29394615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A Case of Recurrent Gastric Cancer with Grade 3 Proteinuria Caused by Ramucirumab plus Paclitaxel Therapy].
    Kimura Y; Makari Y; Mikami J; Hiraki Y; Kato H; Iwama M; Shiraishi O; Yasuda A; Shinkai M; Imano M; Imamoto H; Fujita J; Furukawa H; Yasuda T
    Gan To Kagaku Ryoho; 2017 Nov; 44(12):1080-1082. PubMed ID: 29394540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-Term Disease-Free Survival through Postoperative Chemotherapy in a Case of Gastric Cancer with Peritoneal Dissemination].
    Nakade H; Matsumoto S; Wakatsuki K; Tanaka T; Migita K; Ito M; Kunishige T; Kitano M; Nakatani M; Nakajima Y
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):2055-7. PubMed ID: 26805262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of recurrent gastric cancer with peritoneal dissemination successfully treated over 1 year 8 months with combined chemotherapy of paclitaxel and TS-1].
    Tamura S; Miki H; Nakata K; Kim C; Takiuchi D; Okada K; Okamura S; Aihara T; Sugimoto K; Ohzato H; Tomita N; Takatsuka Y
    Gan To Kagaku Ryoho; 2006 Feb; 33(2):255-7. PubMed ID: 16484868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of advanced gastric cancer with peritoneal dissemination responding remarkably to TS-1/CDDP combination chemotherapy].
    Nishiura H; Ishii K; Nonami M; Shigemori M; Katsurada A; Azechi H; Kondo M; Tojo M; Nishikawa K; Asagoe K; Otani Y; Inoue F; Suwa H; Saiga T
    Gan To Kagaku Ryoho; 2006 Dec; 33(13):2057-60. PubMed ID: 17197753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of highly advanced gastric cancer with peritoneal dissemination -- a histological CR to S-1 and CDDP combination chemotherapy].
    Ito Y; Kurahashi S; Ito S; Misawa K; Niwa Y; Yatabe Y; Shimizu Y
    Gan To Kagaku Ryoho; 2015 Mar; 42(3):355-8. PubMed ID: 25812507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of cytological status of peritoneal lavage fluid during intraperitoneal chemotherapy for gastric cancer with overt peritoneal dissemination.
    Emoto S; Kitayama J; Ishigami H; Yamaguchi H; Watanabe T
    Ann Surg Oncol; 2015 Mar; 22(3):780-6. PubMed ID: 25216603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.